Victoria Roulstone

1.9k total citations
34 papers, 1.3k citations indexed

About

Victoria Roulstone is a scholar working on Genetics, Oncology and Infectious Diseases. According to data from OpenAlex, Victoria Roulstone has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 16 papers in Oncology and 15 papers in Infectious Diseases. Recurrent topics in Victoria Roulstone's work include Virus-based gene therapy research (30 papers), Viral gastroenteritis research and epidemiology (15 papers) and CAR-T cell therapy research (15 papers). Victoria Roulstone is often cited by papers focused on Virus-based gene therapy research (30 papers), Viral gastroenteritis research and epidemiology (15 papers) and CAR-T cell therapy research (15 papers). Victoria Roulstone collaborates with scholars based in United Kingdom, United States and Canada. Victoria Roulstone's co-authors include Kevin J. Harrington, Alan Melcher, Richard G. Vile, Joan Kyula, Matt Coffey, Hardev Pandha, David Mansfield, Katie Twigger, Eleni Karapanagiotou and Martin McLaughlin and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Victoria Roulstone

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victoria Roulstone United Kingdom	21	980	698	425	385	290	34	1.3k
Katie Twigger United Kingdom	13	1.1k 1.1×	571 0.8×	399 0.9×	550 1.4×	352 1.2×	18	1.2k
Philippe Erbs France	21	894 0.9×	586 0.8×	629 1.5×	168 0.4×	239 0.8×	52	1.4k
Kyle B. Stephenson Canada	20	778 0.8×	767 1.1×	385 0.9×	212 0.6×	121 0.4×	27	1.3k
Brad Thompson Canada	10	694 0.7×	396 0.6×	326 0.8×	319 0.8×	204 0.7×	24	869
Christine E. Engeland Germany	18	792 0.8×	674 1.0×	385 0.9×	178 0.5×	125 0.4×	38	1.1k
Dominic G. Roy Canada	18	708 0.7×	644 0.9×	466 1.1×	152 0.4×	164 0.6×	31	1.2k
Siri Tähtinen Finland	20	837 0.9×	1.0k 1.4×	670 1.6×	204 0.5×	226 0.8×	32	1.6k
Diana J.M. van den Wollenberg Netherlands	20	1.0k 1.0×	424 0.6×	640 1.5×	441 1.1×	182 0.6×	39	1.3k
Shaoheng Ni United States	23	1.7k 1.7×	905 1.3×	1.3k 3.1×	470 1.2×	284 1.0×	27	2.1k
Gerd Bauerschmitz Germany	23	1.3k 1.3×	930 1.3×	1.0k 2.4×	153 0.4×	287 1.0×	55	1.6k

Countries citing papers authored by Victoria Roulstone

Since Specialization

Citations

This map shows the geographic impact of Victoria Roulstone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Roulstone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Roulstone more than expected).

Fields of papers citing papers by Victoria Roulstone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Roulstone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Roulstone. The network helps show where Victoria Roulstone may publish in the future.

Co-authorship network of co-authors of Victoria Roulstone

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Roulstone. A scholar is included among the top collaborators of Victoria Roulstone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Roulstone. Victoria Roulstone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hak, Charleen Chan Wah, Emmanuel C. Patin, Annalisa Nicastri, et al.. (2025). Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer. Cancer Research Communications. 5(11). 2079–2091.

Paget, James, Janice Ward, David Mansfield, et al.. (2024). CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues. Molecular Cancer Therapeutics. 24(3). 431–443.

Foo, Shane, Pablo Nenclares, Martin McLaughlin, et al.. (2024). Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for ImmunoTherapy of Cancer. 12(7). e009443–e009443. 5 indexed citations

Roulstone, Victoria, David Mansfield, R. J. C. Harris, et al.. (2021). Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies. Journal for ImmunoTherapy of Cancer. 9(7). e002673–e002673. 10 indexed citations

McLaughlin, Martin, Malin Pedersen, Victoria Roulstone, et al.. (2020). The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism. Molecular Therapy — Oncolytics. 16. 238–249. 24 indexed citations

Smith, Henry, David Mansfield, Victoria Roulstone, et al.. (2019). PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma. Clinical Cancer Research. 25(11). 3443–3454. 23 indexed citations

Thomas, Suzanne, Victoria Roulstone, Joan Kyula, et al.. (2019). Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1. Journal for ImmunoTherapy of Cancer. 7(1). 214–214. 119 indexed citations

Khan, Aadil, James Paget, Martin McLaughlin, et al.. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science Translational Medicine. 10(425). 17 indexed citations

Comins, Charles, Guy R. Simpson, William Rogers, et al.. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer Gene Therapy. 25(5-6). 148–160. 9 indexed citations

10.

Mansfield, David, Joan Kyula, Gabriela Krämer-Marek, et al.. (2016). Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Gene Therapy. 23(4). 357–368. 46 indexed citations

11.

Wilkinson, Michelle, Henry Smith, Joan Kyula, et al.. (2016). Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis. Oncotarget. 7(49). 81208–81222. 24 indexed citations

12.

Roulstone, Victoria, Malin Pedersen, Joan Kyula, et al.. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Molecular Therapy. 23(5). 931–942. 38 indexed citations

13.

Roulstone, Victoria, Khurum Khan, Hardev Pandha, et al.. (2014). Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors. Clinical Cancer Research. 21(6). 1305–1312. 42 indexed citations

14.

Kyula, Joan, Aadil Khan, David Mansfield, et al.. (2013). Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling. Oncogene. 33(13). 1700–1712. 33 indexed citations

15.

Karapanagiotou, Eleni, Victoria Roulstone, Katie Twigger, et al.. (2012). Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies. Clinical Cancer Research. 18(7). 2080–2089. 151 indexed citations

16.

Galanis, Evanthia, Svetomir N. Markovic, Vera J. Suman, et al.. (2012). Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. Molecular Therapy. 20(10). 1998–2003. 125 indexed citations

17.

Twigger, Katie, Victoria Roulstone, Joan Kyula, et al.. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer. 12(1). 368–368. 46 indexed citations

18.

Mansfield, David, Joan Kyula, S. Zaidi, et al.. (2012). Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral Oncology. 49(2). 108–118. 31 indexed citations

19.

Touchefeu, Yann, Aadil Khan, Victoria Roulstone, & Kevin J. Harrington. (2012). Combining External Beam Radiotherapy with Measles-Virus Oncolytic Therapy and SAR-020106, A Novel Radiosensitizer, in Head and Neck Cancer Models. Annals of Oncology. 23. ix537–ix537. 1 indexed citations

20.

Harrington, Kevin J., Eleni Karapanagiotou, Victoria Roulstone, et al.. (2010). Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers. Clinical Cancer Research. 16(11). 3067–3077. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact